Skip to main content
padlock icon - secure page this page is secure

Dysfunction of Glia-Neuron Communication in Pathophysiology of Schizophrenia

Buy Article:

$63.00 + tax (Refund Policy)

Multiple lines of evidence suggest that genetic factors and environmental factors as well as a dysfunction in the glutamatergic neurotransmission contribute to the pathophysiology of schizophrenia. Communication between neurons and glia is essential for axonal conduction, synaptic neurotransmission, and information processing, and thus is required for normal functioning of the nervous system during development and throughout adult life. A number of studies have demonstrated that the substances which communicate between neurons and glia are altered in the blood, cerebrospinal fluid (CSF), and postmortem brain samples of schizophrenic patients. These findings suggest that neuron-glia communication might be impaired in the brains of schizophrenic patients. In this article, we review the imbalance of neuron-glia communication presented in the neurodevelopmental hypothesis as well as the glutamate hypothesis of schizophrenia. First, we discuss the role of growth factors (e.g., basic fibroblast growth factor (bFGF), epidermal growth factor (EGF), midkine), brain-derived neurotrophic factor (BDNF) and cytokines in the pathophysiology of schizophrenia. Second, we focus on the role of endogenous substances (glutamate, glutamine, D-serine, kynurenic acid, and glutathione), which modulate the NMDA receptor function, in the pathophysiology of schizophrenia.
No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: cytokines; d-serine; growth factors; neurotrophic factors; nmda receptor; schizophrenia

Document Type: Review Article

Affiliations: Department of Psychiatry, Chiba University Graduate School of Medicine, 1-8-1 Inohana, Chiba 260- 8670, Japan.

Publication date: 01 June 2005

More about this publication?
  • Current Psychiatry Reviews publishes frontier reviews on all the latest advances on clinical psychiatry and its related areas e.g. pharmacology, epidemiology, clinical care, and therapy. The journal's aim is to publish the highest quality review articles dedicated to clinical research in the field. The journal is essential reading for all clinicians, psychiatrists and researchers in psychiatry.
  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more